Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1964 2
1965 1
1967 2
1969 2
1972 5
1973 2
1974 5
1975 7
1976 8
1977 12
1978 13
1979 12
1980 9
1981 14
1982 13
1983 19
1984 19
1985 19
1986 22
1987 16
1988 16
1989 23
1990 20
1991 30
1992 20
1993 41
1994 26
1995 14
1996 28
1997 19
1998 28
1999 17
2000 24
2001 24
2002 16
2003 19
2004 47
2005 41
2006 39
2007 43
2008 65
2009 80
2010 101
2011 97
2012 94
2013 109
2014 127
2015 114
2016 96
2017 112
2018 115
2019 126
2020 128
2021 137
2022 152
2023 133
2024 115
2025 155
2026 82

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,574 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean nakamoto n[au] (194 results)?
Albumin-Bilirubin Grade Analyses of Atezolizumab plus Bevacizumab versus Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: A Post Hoc Analysis of the Phase III IMbrave150 Study.
Kudo M, Finn RS, Cheng AL, Zhu AX, Ducreux M, Galle PR, Sakamoto N, Kato N, Nakano M, Jia J, Vogel A. Kudo M, et al. Among authors: sakamoto n. Liver Cancer. 2023 Mar 4;12(5):479-493. doi: 10.1159/000529996. eCollection 2023 Oct. Liver Cancer. 2023. PMID: 37901766 Free PMC article.
Characterization of early-onset gastritis during zolbetuximab-containing chemotherapy in CLDN18.2-positive gastric cancer.
Yamamoto K, Owaki Y, Nakayama I, Sakamoto N, Ishizaka M, Kadota T, Okemoto D, Matsubara Y, Miyashita Y, Kobayashi A, Okazaki U, Seguchi K, Hosokai T, Ogura T, Mishima S, Kotani D, Kawazoe A, Hashimoto T, Kuboki Y, Bando H, Kojima T, Yoshino T, Kuwata T, Ishii G, Yano T, Shitara K. Yamamoto K, et al. Among authors: sakamoto n. ESMO Open. 2025 Oct;10(10):105805. doi: 10.1016/j.esmoop.2025.105805. Epub 2025 Sep 30. ESMO Open. 2025. PMID: 41033281 Free PMC article.
Microplastics in Human Bronchoalveolar Lavage Fluid.
Tokito T, Kido T, Nagafuchi O, Tomoshige K, Nakazawa K, Shinozuka K, Sato S, Kido K, Noguchi Y, Matsumoto T, Mizoguchi S, Murakami R, Yura H, Ishimoto H, Takazono T, Sakamoto N, Ishimatsu Y, Tanaka Y, Matsumoto K, Nagayasu T, Mukae H. Tokito T, et al. Among authors: sakamoto n. Respirology. 2025 Dec;30(12):1141-1152. doi: 10.1111/resp.70107. Epub 2025 Aug 22. Respirology. 2025. PMID: 40843955 Free PMC article.
Modeling and addressing on-target/off-tumor toxicity of claudin 18.2 targeted immunotherapies.
Carstens EJ, Takahashi K, Sakamoto N, De Vizio M, Morgado M, Nikkhoi SK, Mangipudi A, Nguyen CH, Weltzin T, Nakayama I, Lv Q, Zeng J, Nie C, Deng C, Wang X, Liu L, Klempner SJ, Ramasubramanian A, Nowak JA, Aguirre AJ, Shitara K, Smith EL. Carstens EJ, et al. Among authors: sakamoto n. Nat Commun. 2025 Nov 1;16(1):9651. doi: 10.1038/s41467-025-65148-6. Nat Commun. 2025. PMID: 41176582 Free PMC article.
Clinical characterization of FGFR2b expression in patients with advanced gastric or gastroesophageal junction adenocarcinoma.
Sato S, Rhodes SL, Aoki Y, Nakayama I, Hashimoto T, Hawkins J, Yanes RE, Chang CH, Nakamura Y, Kawazoe A, Mishima S, Kotani D, Kuboki Y, Bando H, Kojima T, Yoshino S, Reading S, Honeycutt H, Finger E, Endo I, Sakamoto N, Kuwata T, Yoshino T, Shitara K. Sato S, et al. Among authors: sakamoto n. ESMO Open. 2025 Jul;10(7):105322. doi: 10.1016/j.esmoop.2025.105322. Epub 2025 Jun 12. ESMO Open. 2025. PMID: 40513139 Free PMC article.
Landscape Analysis of CLDN18 Expression and Isoform Distribution in Solid Tumors: Insights From MONSTAR-SCREEN-2 Study.
Hashimoto T, Iida N, Nakamura Y, Nonomura N, Morizane C, Iwata H, Okano S, Yamagami W, Yamazaki N, Kadowaki S, Ueno M, Boku S, Oki E, Komatsu Y, Yuki S, Makiyama A, Ogata T, Takahashi N, Okano N, Nishina T, Sakamoto N, Kuwata T, Yamashita R, Shibuki T, Imai M, Fujisawa T, Bando H, Shitara K, Yoshino T. Hashimoto T, et al. Among authors: sakamoto n. Cancer Sci. 2025 Aug;116(8):2218-2231. doi: 10.1111/cas.70100. Epub 2025 Jun 2. Cancer Sci. 2025. PMID: 40455642 Free PMC article.
Efficacy and Safety of Intravenous-to-Oral Lascufloxacin Switch Therapy in Community-Onset Pneumonia: A Single-Arm, Open-Label Clinical Trial.
Iwanaga N, Hosogaya N, Takazono T, Tsukamoto Y, Morio R, Irifune S, Miyamura T, Harada Y, Nagayoshi Y, Kondo A, Mihara T, Kohno Y, Fukuda Y, Kobayashi T, Sasaki E, Sawai T, Imamura Y, Morikawa T, Hashiguchi K, Futsuki Y, Inoue Y, Fukushima K, Suyama N, Senju H, Tanaka H, Kawazoe Y, Morimoto S, Ito Y, Yoshida M, Takeda K, Ide S, Sakamoto N, Izumikawa K, Yanagihara K, Mukae H. Iwanaga N, et al. Among authors: sakamoto n. Cureus. 2025 Mar 11;17(3):e80404. doi: 10.7759/cureus.80404. eCollection 2025 Mar. Cureus. 2025. PMID: 40078884 Free PMC article.
MS-DIAL 5 multimodal mass spectrometry data mining unveils lipidome complexities.
Takeda H, Matsuzawa Y, Takeuchi M, Takahashi M, Nishida K, Harayama T, Todoroki Y, Shimizu K, Sakamoto N, Oka T, Maekawa M, Chung MH, Kurizaki Y, Kiuchi S, Tokiyoshi K, Buyantogtokh B, Kurata M, Kvasnička A, Takeda U, Uchino H, Hasegawa M, Miyamoto J, Tanabe K, Takeda S, Mori T, Kumakubo R, Tanaka T, Yoshino T, Okamoto M, Takahashi H, Arita M, Tsugawa H. Takeda H, et al. Among authors: sakamoto n. Nat Commun. 2024 Nov 28;15(1):9903. doi: 10.1038/s41467-024-54137-w. Nat Commun. 2024. PMID: 39609386 Free PMC article.
Three-year overall survival in unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Ohara M, Suda G, Kohya R, Yasui Y, Tsuchiya K, Kurosaki M, Tani J, Maekawa S, Enomoto N, Chuma M, Morimoto M, Kaneko S, Nakagawa M, Asahina Y, Komori A, Kugiyama Y, Baba M, Nakamura A, Ito J, Yamada R, Hosoda S, Yamamoto Y, Yoshida S, Sho T, Sasaki T, Yoda T, Meno A, Yasuura N, Fu Q, Yang Z, Maehara O, Ohnishi S, Tokuchi Y, Kitagataya T, Kawagishi N, Nakai M, Ogawa K, Sakamoto N. Ohara M, et al. Among authors: sakamoto n. Hepatol Int. 2025 Dec;19(6):1371-1381. doi: 10.1007/s12072-025-10875-7. Epub 2025 Aug 28. Hepatol Int. 2025. PMID: 40875102
2,574 results